Although standard HF treatment (RAAS inhibitors, sodium–glucose co-transporter-2 (SGLT2) inhibitors) improves proteinuria and limits long-term decline in kidney function [36,37], vitamin D supplementation might also help prevent and reduce the progression of chronic kidney disease (CKD) in HF. The gene discussed is SLC5A2; the disease is chronic kidney disease.